Salix Pharmaceuticals (SLXP) Says FDA Approves Supplemental NDA for Changes to Approved Labeling for COLAZAL
Tweet Send to a Friend
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) announces that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
